CrowdStrike crosses above analyst targets as short sellers keep exiting

CRWD closed at $268.02 on Tuesday, up 17.9% on the week, a move that has now carried the stock cleanly through the $247.25 consensus mean target it crossed on the way up last week.

The short position has continued to deflate, and the pace has accelerated. SI fell to 9.4% of free float by Tuesday, down from 10.1% last Thursday and from a recent peak near 10.7% in early October. That represents roughly 2.3 million fewer shares short over the past week alone. The borrow market offers no evidence of a mechanical squeeze. Cost to borrow is 0.39%, down 12% on the week and close to a multi-month low. Availability is effectively unconstrained, with over a billion shares available to lend. The short unwind looks voluntary, not forced. Options positioning reinforces that read: the put/call ratio is 0.99, fractionally below its 20-day average of 0.99 and slightly below neutral, not a defensive setup. There is no spike in downside hedging accompanying the rally.

The Street has continued to upgrade its view even as the stock rose to meet the targets. Mizuho raised its target to $275 last week, the most recent move from a named firm, putting it just above current levels. The broader pattern of the past three weeks is a cluster of raises from Wells Fargo at $300, Citigroup at $295, BTIG at $312, BMO at $295 and Needham at $310, all maintaining positive ratings. The consensus target at $247.25 now sits below the stock price, which means the Street is, for the first time in this cycle, running behind the tape rather than ahead of it. The lone dissenter remains an Amerx Underweight initiation at $212. The bull case rests on Falcon platform cross-sell economics, AI security budget conversion with Falcon Guardian estimated at a $55 million to $60 million run rate, and free cash flow margins heading toward the high 30s. Bears point to the sensor update reputational tail, deal conversion slowdowns, and a valuation that prices in 24% revenue CAGR through 2031 with little room for error. The P/E is 173 and EV/EBITDA is 118, both at the upper end of their 30-day ranges as the stock has re-rated higher. Forward EPS momentum ranks in the 94th percentile of the ORTEX universe, which partly explains why the Street has kept raising numbers even through the difficult period.

CRWD's 17.9% weekly gain is roughly in line with the cybersecurity peer group. PANW added 18.1% over the same period, RBRK gained 18.5%, and S rose 16.6%. TENB outpaced the group at 24.8%, and NTSK led with a 31.9% weekly move. FTNT lagged at 8.2%. The sector bid is broad and genuine, which makes CRWD's recovery look less idiosyncratic than it might appear in isolation.

CEO George Kurtz sold approximately $2.5 million of stock on October 26 across multiple tranches, all under a pre-arranged 10b5-1 plan. The net 90-day insider figure is negative $12.5 million. Pre-planned sales carry less signal than discretionary transactions, but the 90-day net is worth noting as the stock approaches levels where plan-driven selling is more likely to be active.

Wikipedia attention for CRWD is running 2.7 standard deviations above its own 90-day average as of October 26, the highest retail attention reading in the ORTEX alt-data layer for this stock in recent months. That spike in public interest coincides exactly with the price recovery, and the next earnings print is scheduled for December 1, 34 days away. Whether the stock can hold above the consensus mean target, or analysts revise that target higher again before the print, is the clearest thing to watch between now and then.